Funding Opportunities
Current Funding Opportunities
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Notice of Upcoming Prize Competition Announcement for the TARGETED (Targeted Genome Editor Delivery) Challenge
|
03/15/2023 | NOT-RM-23-008 | Somatic Cell Genome Editing Program
|
Anticipated Submission Due Date: 10/05/2023 |
Archived Funding Opportunities
- Platform Clinical Trials of Somatic Genome Editing for Multiple Diseases (UG3/UH3, Clinical Trial Required) RFA-RM-22-016
- Somatic Cell Genome Editing Translational Coordination and Dissemination Center (U24, Clinical Trial Not Allowed) RFA-RM-22-017
- IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed) RFA-RM-22-015
- Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) RFA-RM-22-014
- Notice of Pre-Application Webinar for the NIH Common Fund Somatic Cell Genome Editing program
NOT-RM-18-020 - Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Genome Editing (U01 Clinical Trial Not Allowed)
RFA-RM-18-022 - Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
RFA-RM-18-023 - Expanding the Human Genome Engineering Repertoire (U01 Clinical Trial Not Allowed)
RFA-RM-18-024 - Innovative Technologies to Non-Invasively Monitor Genome Edited Cells In Vivo (UH2/UH3 Clinical Trial Not Allowed)
RFA-RM-18-025 - Large Animal Testing Centers for Evaluation of Somatic Cell Genome Editing Tools (U42 - Clinical Trial Not Allowed)
RFA-RM-18-014 - Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed)
RFA-RM-18-012 - Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed)
RFA-RM-18-013 - Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)
RFA-RM-18-015 - Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
RFA-RM-18-016 - Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed)
RFA-RM-18-017 - Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)
RFA-RM-18-018
This page last reviewed on March 16, 2023